0001415889-17-000415.txt : 20170314 0001415889-17-000415.hdr.sgml : 20170314 20170314172617 ACCESSION NUMBER: 0001415889-17-000415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170312 FILED AS OF DATE: 20170314 DATE AS OF CHANGE: 20170314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChromaDex Corp. CENTRAL INDEX KEY: 0001386570 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 262940963 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10005 MUIRLANDS BLVD. STREET 2: STE. G, FIRST FLOOR CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-419-0288 MAIL ADDRESS: STREET 1: 10005 MUIRLANDS BLVD. STREET 2: STE. G, FIRST FLOOR CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: CODY RESOURCES, INC. DATE OF NAME CHANGE: 20070112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fried Robert N CENTRAL INDEX KEY: 0001417952 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37752 FILM NUMBER: 17689031 MAIL ADDRESS: STREET 1: 100 NORTH CRESCENT DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90210 4 1 form4-03142017_020307.xml X0306 4 2017-03-12 0001386570 ChromaDex Corp. CDXC 0001417952 Fried Robert N 10005 MUIRLANDS BLVD SUITE G IRVINE CA 92618 true true false false PRESIDENT, CHIEF STRATEGY OFF. Common Stock 2017-03-12 4 A 0 339595 2.72 A 406574 D Common Stock 2017-03-12 4 A 0 166667 0 A 573241 D Common Stock 12744 I See Footnote 3 Employee Stock Options (right to buy) 2.715 2017-03-12 4 A 0 500000 0 A 2017-04-12 2027-03-12 Common Stock 500000 500000 D Received in exchange for the membership interests of Healthspan Research, LLC ("Healthspan") previously owned by the Reporting Person, valued at $923,697.41, in connection with the acquisition of the outstanding membership interests of Healthspan by ChromaDex Corporation (the "Company") (the "Acquisition"). The number of shares received by the Reporting Person was calculated using the closing bid price per share of the Company's common stock on the NASDAQ Capital Market on the last trading day before the effective date of the Acquisition, rounded up to the nearest share. The closing bid price of the Company's common stock on March 10, 2017, rounded up to the nearest share, was $2.72 per share. These are shares of restricted stock and were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer. 1/3rd will vest on March 12, 2018, 1/3rd will vest on March 12, 2019 and 1/3rd will vest on March 12, 2020. 6,744 shares held by Jeremy Fried and 6,000 shares held by Benjamin Fried, who are both sons of Robert Fried. The options were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer. Options vest in equal monthly installments over three years. /s/ Robert Fried 2017-03-14